Ingalls & Snyder LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $2.56 Billion distributed in 461 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Corcept Therapeutics Inc with a value of $383M, Exxon Mobil Corp with a value of $104M, Apple Inc. with a value of $102M, Microsoft Corp with a value of $92.9M, and Canadian Natural Resources LTD with a value of $90.3M.

Examining the 13F form we can see an increase of $237M in the current position value, from $2.33B to 2.56B.

Ingalls & Snyder LLC is based out at New York, NY

Below you can find more details about Ingalls & Snyder LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.56 Billion
Healthcare: $609 Million
Energy: $349 Million
Technology: $339 Million
Financial Services: $328 Million
Industrials: $208 Million
Communication Services: $168 Million
Consumer Cyclical: $160 Million
Consumer Defensive: $117 Million
Other: $229 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 461
  • Current Value $2.56 Billion
  • Prior Value $2.33 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 36 stocks
  • Additional Purchases 126 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 150 stocks
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.